176 related articles for article (PubMed ID: 12673162)
1. Positron emission and computed X-ray tomography: a coming together.
Costa DC; Visvikis D; Crosdale I; Pigden I; Townsend C; Bomanji J; Prvulovich E; Lonn A; Ell PJ
Nucl Med Commun; 2003 Apr; 24(4):351-8. PubMed ID: 12673162
[TBL] [Abstract][Full Text] [Related]
2. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
Cohade C; Wahl RL
Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
[TBL] [Abstract][Full Text] [Related]
3. An introduction to PET-CT imaging.
Kapoor V; McCook BM; Torok FS
Radiographics; 2004; 24(2):523-43. PubMed ID: 15026598
[TBL] [Abstract][Full Text] [Related]
4. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
Visvikis D; Costa DC; Croasdale I; Lonn AH; Bomanji J; Gacinovic S; Ell PJ
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):344-53. PubMed ID: 12634961
[TBL] [Abstract][Full Text] [Related]
5. PET/CT scanners: a hardware approach to image fusion.
Townsend DW; Beyer T; Blodgett TM
Semin Nucl Med; 2003 Jul; 33(3):193-204. PubMed ID: 12931321
[TBL] [Abstract][Full Text] [Related]
6. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
7. Preoperative image fusion of fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography data sets in oral maxillofacial carcinoma: potential clinical value.
Wolf G; Nicoletti R; Schultes G; Schwarz T; Schaffler G; Aigner RM
J Comput Assist Tomogr; 2003; 27(6):889-95. PubMed ID: 14600456
[TBL] [Abstract][Full Text] [Related]
8. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
[TBL] [Abstract][Full Text] [Related]
9. The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
Tsai CC; Tsai CS; Ng KK; Lai CH; Hsueh S; Kao PF; Chang TC; Hong JH; Yen TC
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1674-83. PubMed ID: 12937950
[TBL] [Abstract][Full Text] [Related]
10. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
11. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
Bar-Shalom R; Yefremov N; Guralnik L; Gaitini D; Frenkel A; Kuten A; Altman H; Keidar Z; Israel O
J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408
[TBL] [Abstract][Full Text] [Related]
12. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
[TBL] [Abstract][Full Text] [Related]
13. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.
Schöder H; Larson SM; Yeung HW
J Nucl Med; 2004 Jan; 45 Suppl 1():72S-81S. PubMed ID: 14736838
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
Cook GJ; Wegner EA; Fogelman I
Semin Nucl Med; 2004 Apr; 34(2):122-33. PubMed ID: 15031812
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT in oncology: "raising the bar".
Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
17. PET/CT: artifacts caused by bowel motion.
Nakamoto Y; Chin BB; Cohade C; Osman M; Tatsumi M; Wahl RL
Nucl Med Commun; 2004 Mar; 25(3):221-5. PubMed ID: 15094438
[TBL] [Abstract][Full Text] [Related]
18. PET/CT in oncology--a major advance.
Wechalekar K; Sharma B; Cook G
Clin Radiol; 2005 Nov; 60(11):1143-55. PubMed ID: 16223611
[TBL] [Abstract][Full Text] [Related]
19. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
Kinahan PE; Hasegawa BH; Beyer T
Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
[TBL] [Abstract][Full Text] [Related]
20. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]